Skip to main content
Log in

The role of the liver in theophylline elimination

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Theophylline is believed to be largely eliminated from the body by biotransformation in the liver. Using a hepatectomized dog model, we quantitatively assessed the role of the liver in theophylline elimination. The elimination half-life (t½(β)) increased 348% from 9.82±2.39 h in the control group to 43.99±43.53 h in the hepatectomized group of dogs. The serum clearance (Cl(S)) decreased 70% from 0.060±0.017 l/kg/h in the control group to 0.018±0.009 l/kg/h in the hepatectomized group. The volume of distribution (Vd(β)) decreased 10% from 0.81±0.09 l/kg in the control group to 0.73±0.07 l/kg in the hepatectomy group. The mean protein binding of theophylline in dog serum of 9% is low compared to 53–65% in man. In man and the dog, the serum clearance of theophylline is a reasonable reflection of hepatic clearance. Despite the absence of hepatic clearance in the hepatectomized dog, elimination of theophylline continues to a degree.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aranda JV, Sitar DS, Parsons WD, Loughnan PM, Neims AH (1976) Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 293: 413–416

    Article  Google Scholar 

  2. Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem 228: 315–323

    PubMed  CAS  Google Scholar 

  3. Cummins LH, Kozak PP Jr, Gillman SA (1977) Erythromycin’s effect on theophylline blood level. Pediatrics 59: 144–145

    Google Scholar 

  4. de Souich P, McLean AJ, Lalka D, Erill S, Gibaldi M (1978) Pulmonary disease and drug kinetics. Clin Pharmacokinet 3: 257–271

    PubMed  Google Scholar 

  5. Downie, NM, Starry AR (1977) Descriptive and inferential statistics. Harper and Row, New York, p 244

    Google Scholar 

  6. Firor WM, Stinson E Jr (1929) Total extirpation of the dog’s liver in one stage. Bull Johns Hopkins Hosp 44: 138–148

    Google Scholar 

  7. Frank ED, Frank HA, Jacob SW, Fine J (1962) Hepatic blood flow in experimental hemorrhagic shock. Am J Physiol 202: 7–11

    PubMed  CAS  Google Scholar 

  8. Hendeles L, Bighley L, Richardson RH, Hepler CD, Carmichael J (1977) Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 11: 12–18

    Google Scholar 

  9. Hendeles L, Weinberger M (1980) Poisoning patients with intravenous theophylline. Am J Hosp Pharm 37: 49–50

    PubMed  CAS  Google Scholar 

  10. Hendeles L, Weinberger M, Bighley L (1978) Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 118: 97–103

    PubMed  CAS  Google Scholar 

  11. Jenne JJ, Nagasawa HT, Thompson RD (1976) Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19: 375–381

    PubMed  CAS  Google Scholar 

  12. Jenne JW, Wyze E, Rood FS, MacDonald FM (1972) Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13: 349–360

    PubMed  CAS  Google Scholar 

  13. Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR (1979) Plasma binding of benzodiazepines in man. J Pharm Sci 68: 1320–1322

    Article  PubMed  CAS  Google Scholar 

  14. Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68: 1358–1366

    Article  PubMed  CAS  Google Scholar 

  15. Levy G, Koysooko R (1976) Renal clearance of theophylline in man. J Clin Pharmacol 16: 329–332

    PubMed  CAS  Google Scholar 

  16. Lohman SM, Miech RP (1976) Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther 196: 213–225

    Google Scholar 

  17. Mangione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ (1978) Pharmacokinetics of theophylline in hepatic disease. Chest 73: 616–622

    PubMed  CAS  Google Scholar 

  18. Matthay RA, Matthay MA, Weinberger MM (1976) Grand mal seizure induced by oral theophylline. Thorax 31: 470–471

    Article  PubMed  CAS  Google Scholar 

  19. Metzler CM, Elfring GL, McEwen AJ (1974) A users manual for NONLIN and associated programs. Research Biostatistics, Upjohn Co, Kalamazoo, Michigan

    Google Scholar 

  20. Nielsen-Kudsk F, Magnussen I, Jakobsen P (1978) Pharmacokinetics of theophylline in ten elderly patients. Acta Pharmacol Toxicol [Kbh] 42: 226–234

    CAS  Google Scholar 

  21. Pfeifer HJ, Greenblatt DJ (1978) Clinical toxicity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. Chest 73: 455–459

    PubMed  CAS  Google Scholar 

  22. Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI (1977) Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med 296: 1495–1497

    Article  PubMed  CAS  Google Scholar 

  23. Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI (1977) Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther 21: 310–316

    PubMed  CAS  Google Scholar 

  24. Roberts RK, Wilkinson GR, Branch RA, Schenker S (1978) Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). Gastroenterology 75: 479–485

    PubMed  CAS  Google Scholar 

  25. Sample RHB, Glick MR, Oei JO (1979) The influence of a new, improved theophylline assay procedure on laboratory analyses. J Indiana State Med Assoc 72: 349–352

    PubMed  CAS  Google Scholar 

  26. Shoemaker WC, Van Itallie TB, Walker WF (1959) Measurement of hepatic glucose output and hepatic blood flow in response to glucagon. Am J Physiol 196: 315–318

    PubMed  CAS  Google Scholar 

  27. Wagner JG (1976) Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 4: 443–467

    Article  PubMed  CAS  Google Scholar 

  28. Weinberger M, Hudgel D, Spector S, Chidsey C (1977) Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol 59: 228–231

    Article  PubMed  CAS  Google Scholar 

  29. Wilkinson GR, Schenker S (1976) Effects of liver disease on drug disposition in man. Biochem Pharmacol 25: 2675–2681

    Article  PubMed  CAS  Google Scholar 

  30. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brashear, R.E., Nelson, R.L., Glick, M.R. et al. The role of the liver in theophylline elimination. Lung 158, 101–109 (1980). https://doi.org/10.1007/BF02713709

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02713709

Key words

Navigation